ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,995.54
      0.38%
      US Tech 100
      20,560.00
      0.09%
      Dow Jones
      43,988.99
      0.59%
      Brent Oil
      73.93
      -2.03%
      Bitcoin
      76,532.85
      0.83%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Amneal Pharmaceuticals Holding Co (AMRX)

      7. Amneal Pharmaceuticals Holding Co (AMRX) News

      AMRX

      Amneal Pharmaceuticals (AMRX)

      Amneal Pharmaceuticals Holding Co
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:AMRX
      DateTimeSourceHeadlineSymbolCompany
      09/05/20244:05PMBusiness WireAmneal and Shilpa Announce U.S. FDA Approval of BORUZU™, the First Ready-to-Use Version of Bortezomib for subcutaneous administrationNYSE:AMRXAmneal Pharmaceuticals Holding Co
      08/20/202411:26AMBusiness WireAmneal Receives U.S. FDA Approval for Propofol Injectable Emulsion Single Dose VialsNYSE:AMRXAmneal Pharmaceuticals Holding Co
      08/20/20248:00AMBusiness WireAmneal Receives U.S. FDA Approval for Propofol Injectable Emulsion Single Dose VialsNYSE:AMRXAmneal Pharmaceuticals Holding Co
      08/14/20243:12PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
      08/14/202411:04AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
      08/14/20245:56AMIH Market NewsUBS Beats Earnings Forecasts, Intel Divests Arm Holdings, Flutter Surges 9% in Premarket Trading, and MoreNYSE:AMRXAmneal Pharmaceuticals Holding Co
      08/09/20246:05AMBusiness WireAmneal Reports Second Quarter 2024 Financial ResultsNYSE:AMRXAmneal Pharmaceuticals Holding Co
      08/07/20244:45PMBusiness WireAmneal Receives U.S. FDA Approval for IPX203 for Treatment of Parkinson’s Disease to Be Launched as CREXONT® (Carbidopa and Levodopa) Extended-Release CapsulesNYSE:AMRXAmneal Pharmaceuticals Holding Co
      07/29/20244:05PMBusiness WireAmneal Receives U.S. FDA Approval for Potassium Phosphates Injection IV BagsNYSE:AMRXAmneal Pharmaceuticals Holding Co
      07/11/20244:05PMBusiness WireAmneal to Report Second Quarter 2024 Results on August 9, 2024NYSE:AMRXAmneal Pharmaceuticals Holding Co
      07/09/20244:05PMBusiness WireAmneal Launches FOCINVEZ™, the First Ready-to-Use Version of FosaprepitantNYSE:AMRXAmneal Pharmaceuticals Holding Co
      07/01/20248:00AMBusiness WireKashiv BioSciences Enters into Exclusive Licensing Agreement with Amneal for Commercialization of a Proposed Biosimilar to XOLAIR® (Omalizumab)NYSE:AMRXAmneal Pharmaceuticals Holding Co
      07/01/20248:00AMBusiness WireAmneal Expands Biosimilars Portfolio to Eight Products with Addition of Omalizumab BiosimilarNYSE:AMRXAmneal Pharmaceuticals Holding Co
      06/28/20248:00AMBusiness WireAmneal Releases 2023 Environmental, Social and Governance ReportNYSE:AMRXAmneal Pharmaceuticals Holding Co
      06/05/20248:00AMBusiness WireAmneal Expands Broad Injectables Portfolio to Over 40 Products with the Addition of Six New TherapiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
      05/22/20244:05PMBusiness WireAmneal to Participate at Upcoming Investor ConferenceNYSE:AMRXAmneal Pharmaceuticals Holding Co
      05/22/20244:05PMBusiness WireAmneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of CaliforniaNYSE:AMRXAmneal Pharmaceuticals Holding Co
      05/16/20243:13PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
      05/16/20243:13PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
      05/14/20244:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
      05/14/20244:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
      05/14/20244:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
      05/14/20244:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
      05/07/20244:18PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:AMRXAmneal Pharmaceuticals Holding Co
      05/06/20245:35PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
      05/06/20245:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
      05/06/20245:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
      05/06/20245:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
      05/06/20245:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
      05/03/20246:14AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:AMRXAmneal Pharmaceuticals Holding Co
       Showing the most relevant articles for your search:NYSE:AMRX